Eagle Bay Advisors’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-710
| Closed | -$2.08K | – | 116 |
|
|
2024
Q4 | $2.08K | Hold |
710
| – | – | ﹤0.01% | 871 |
|
|
2024
Q3 | $1.85K | Hold |
710
| – | – | ﹤0.01% | 1242 |
|
|
2024
Q2 | $2.1K | Hold |
710
| – | – | ﹤0.01% | 880 |
|
|
2024
Q1 | $3.22K | Hold |
710
| – | – | ﹤0.01% | 819 |
|
|
2023
Q4 | $4.05K | Hold |
710
| – | – | ﹤0.01% | 667 |
|
|
2023
Q3 | $3.27K | Hold |
710
| – | – | ﹤0.01% | 719 |
|
|
2023
Q2 | $4.59K | Buy |
710
+355
| +100% | +$2.29K | ﹤0.01% | 677 |
|
|
2023
Q1 | $2.68K | Hold |
355
| – | – | ﹤0.01% | 727 |
|
|
2022
Q4 | $3.6K | Sell |
355
-900
| -72% | -$9.12K | ﹤0.01% | 693 |
|
|
2022
Q3 | $12K | Hold |
1,255
| – | – | 0.01% | 566 |
|
|
2022
Q2 | $13.4K | Buy |
+1,255
| New | +$13.4K | 0.01% | 597 |
|
|
2022
Q1 | – | Sell |
-4,463
| Closed | -$85K | – | 292 |
|
|
2021
Q4 | $85K | Buy |
4,463
+1,363
| +44% | +$26K | 0.05% | 215 |
|
|
2021
Q3 | $62K | Buy |
3,100
+1,300
| +72% | +$26K | 0.03% | 330 |
|
|
2021
Q2 | $40K | Buy |
+1,800
| New | +$40K | 0.03% | 391 |
|